Company intelligence / Profile preview

Aquavet

6th of October City, Giza, Egypt

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Aquavet is a pharmaceutical company specializing in the development, manufacturing, and distribution of veterinary medicines and feed additives. Based in Egypt, the company focuses on providing high-quality health solutions for poultry, livestock, and the growing aquaculture sector. Their product portfolio includes antibiotics, antiparasitics, vitamins, and specialized nutritional supplements designed to improve animal productivity and welfare. Aquavet serves both domestic and international markets, positioning itself as a key player in the Middle Eastern animal health industry.

Therapeutic areas: OtherInfectious Diseases
Modalities: Small moleculeVaccineProtein
Industry: Veterinary

Beyond the preview

Go deeper on Aquavet.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aquavet.

Explore the full profile